In a relatively large clinical sample, this study found that the expression levels of BMAL1, CLOCK, CRY1, PER1, and PER2 in the PBMCs, as well as plasma melatonin levels of PD patients, are significantly decreased compared with HC. This evidence concerns the gene BMAL1 and Parkinson disease.